FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4376223895> ?p ?o ?g. }

• W4376223895 endingPage "462" @default.
• W4376223895 startingPage "445" @default.
• W4376223895 abstract "Background & AimsImmune checkpoint blockade therapy benefits only a small subset of patients with colorectal cancer (CRC), and identification of CRC-intrinsic events modulating immune checkpoint blockade efficacy is an unmet need. We found that AlkB homolog 5 (ALKBH5), an RNA N6-methyladenosine eraser, drives immunosuppression and is a molecular target to boost immune checkpoint blockade therapy in CRC.MethodsClinical significance of ALKBH5 was evaluated in human samples (n = 205). Function of ALKBH5 was investigated in allografts, CD34+ humanized mice, and Alkbh5 knockin mice. Immunity change was determined by means of flow cytometry, immunofluorescence, and functional investigation. Methylated RNA immunoprecipitation sequencing and RNA sequencing were used to identify ALKBH5 targets. Vesicle-like nanoparticle–encapsulated ALKBH5-small interfering RNA was constructed for targeting ALKBH5 in vivo.ResultsHigh ALKBH5 expression predicts poor prognosis in CRC. ALKBH5 induced myeloid-derived suppressor cell accumulation but reduced natural killer cells and cytotoxic CD8+ T cells to induce colorectal tumorigenesis in allografts, CD34+ humanized mice, and intestine-specific Alkbh5 knockin mice. Mechanistically, AXIN2, a Wnt suppressor, was identified as a target of ALKBH5. ALKBH5 binds and demethylates AXIN2 messenger RNA, which caused its dissociation from N6-methyladenosine reader IGF2BP1 and degradation, resulting in hyperactivated Wnt/β-catenin. Subsequently, Wnt/β-catenin targets, including Dickkopf-related protein 1 (DKK1) were induced by ALKBH5. ALKBH5-induced DKK1 recruited myeloid-derived suppressor cells to drive immunosuppression in CRC, and this effect was abolished by anti-DKK1 in vitro and in vivo. Finally, vesicle-like nanoparticle–encapsulated ALKBH5-small interfering RNA, or anti-DKK1 potentiated anti-PD1 treatment in suppressing CRC growth by enhancing antitumor immunity.ConclusionsThis study identified an ALKBH5-N6-methyladenosine-AXIN2-Wnt-DKK1 axis in CRC, which drives immune suppression to facilitate tumorigenesis. Targeting of ALKBH5 is a promising strategy for sensitizing CRC to immunotherapy. Immune checkpoint blockade therapy benefits only a small subset of patients with colorectal cancer (CRC), and identification of CRC-intrinsic events modulating immune checkpoint blockade efficacy is an unmet need. We found that AlkB homolog 5 (ALKBH5), an RNA N6-methyladenosine eraser, drives immunosuppression and is a molecular target to boost immune checkpoint blockade therapy in CRC. Clinical significance of ALKBH5 was evaluated in human samples (n = 205). Function of ALKBH5 was investigated in allografts, CD34+ humanized mice, and Alkbh5 knockin mice. Immunity change was determined by means of flow cytometry, immunofluorescence, and functional investigation. Methylated RNA immunoprecipitation sequencing and RNA sequencing were used to identify ALKBH5 targets. Vesicle-like nanoparticle–encapsulated ALKBH5-small interfering RNA was constructed for targeting ALKBH5 in vivo. High ALKBH5 expression predicts poor prognosis in CRC. ALKBH5 induced myeloid-derived suppressor cell accumulation but reduced natural killer cells and cytotoxic CD8+ T cells to induce colorectal tumorigenesis in allografts, CD34+ humanized mice, and intestine-specific Alkbh5 knockin mice. Mechanistically, AXIN2, a Wnt suppressor, was identified as a target of ALKBH5. ALKBH5 binds and demethylates AXIN2 messenger RNA, which caused its dissociation from N6-methyladenosine reader IGF2BP1 and degradation, resulting in hyperactivated Wnt/β-catenin. Subsequently, Wnt/β-catenin targets, including Dickkopf-related protein 1 (DKK1) were induced by ALKBH5. ALKBH5-induced DKK1 recruited myeloid-derived suppressor cells to drive immunosuppression in CRC, and this effect was abolished by anti-DKK1 in vitro and in vivo. Finally, vesicle-like nanoparticle–encapsulated ALKBH5-small interfering RNA, or anti-DKK1 potentiated anti-PD1 treatment in suppressing CRC growth by enhancing antitumor immunity. This study identified an ALKBH5-N6-methyladenosine-AXIN2-Wnt-DKK1 axis in CRC, which drives immune suppression to facilitate tumorigenesis. Targeting of ALKBH5 is a promising strategy for sensitizing CRC to immunotherapy." @default.
• W4376223895 created "2023-05-13" @default.
• W4376223895 creator A5007428412 @default.
• W4376223895 creator A5014153224 @default.
• W4376223895 creator A5016622934 @default.
• W4376223895 creator A5024721864 @default.
• W4376223895 creator A5026491095 @default.
• W4376223895 creator A5027883179 @default.
• W4376223895 creator A5050721657 @default.
• W4376223895 creator A5050884242 @default.
• W4376223895 creator A5059179110 @default.
• W4376223895 creator A5062903733 @default.
• W4376223895 creator A5063594311 @default.
• W4376223895 creator A5067832646 @default.
• W4376223895 creator A5069893086 @default.
• W4376223895 creator A5072676408 @default.
• W4376223895 creator A5076016269 @default.
• W4376223895 creator A5083944564 @default.
• W4376223895 creator A5091927737 @default.
• W4376223895 date "2023-08-01" @default.
• W4376223895 modified "2023-10-10" @default.
• W4376223895 title "ALKBH5 Drives Immune Suppression Via Targeting AXIN2 to Promote Colorectal Cancer and Is a Target for Boosting Immunotherapy" @default.
• W4376223895 cites W1491936665 @default.
• W4376223895 cites W1554815317 @default.
• W4376223895 cites W1591462558 @default.
• W4376223895 cites W1974595623 @default.
• W4376223895 cites W2002404925 @default.
• W4376223895 cites W2023407460 @default.
• W4376223895 cites W2039215669 @default.
• W4376223895 cites W2053387216 @default.
• W4376223895 cites W2085106808 @default.
• W4376223895 cites W2093488681 @default.
• W4376223895 cites W2104584195 @default.
• W4376223895 cites W2110271242 @default.
• W4376223895 cites W2138972118 @default.
• W4376223895 cites W2188814137 @default.
• W4376223895 cites W2262414037 @default.
• W4376223895 cites W2339653391 @default.
• W4376223895 cites W2501488762 @default.
• W4376223895 cites W2533922074 @default.
• W4376223895 cites W2546967042 @default.
• W4376223895 cites W2563912688 @default.
• W4376223895 cites W2597802455 @default.
• W4376223895 cites W2600626962 @default.
• W4376223895 cites W2600862208 @default.
• W4376223895 cites W2739132742 @default.
• W4376223895 cites W2747205584 @default.
• W4376223895 cites W2770747479 @default.
• W4376223895 cites W2793633504 @default.
• W4376223895 cites W2793785833 @default.
• W4376223895 cites W2793984726 @default.
• W4376223895 cites W2794217370 @default.
• W4376223895 cites W2801309958 @default.
• W4376223895 cites W2804272342 @default.
• W4376223895 cites W2805703720 @default.
• W4376223895 cites W2889646458 @default.
• W4376223895 cites W2890499629 @default.
• W4376223895 cites W2898712541 @default.
• W4376223895 cites W2899264175 @default.
• W4376223895 cites W2903866613 @default.
• W4376223895 cites W2941225619 @default.
• W4376223895 cites W2947674709 @default.
• W4376223895 cites W2972886843 @default.
• W4376223895 cites W3001859997 @default.
• W4376223895 cites W3028187297 @default.
• W4376223895 cites W3047095839 @default.
• W4376223895 cites W3047821845 @default.
• W4376223895 cites W4200260682 @default.
• W4376223895 doi "https://doi.org/10.1053/j.gastro.2023.04.032" @default.
• W4376223895 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37169182" @default.
• W4376223895 hasPublicationYear "2023" @default.
• W4376223895 type Work @default.
• W4376223895 citedByCount "2" @default.
• W4376223895 countsByYear W43762238952023 @default.
• W4376223895 crossrefType "journal-article" @default.
• W4376223895 hasAuthorship W4376223895A5007428412 @default.
• W4376223895 hasAuthorship W4376223895A5014153224 @default.
• W4376223895 hasAuthorship W4376223895A5016622934 @default.
• W4376223895 hasAuthorship W4376223895A5024721864 @default.
• W4376223895 hasAuthorship W4376223895A5026491095 @default.
• W4376223895 hasAuthorship W4376223895A5027883179 @default.
• W4376223895 hasAuthorship W4376223895A5050721657 @default.
• W4376223895 hasAuthorship W4376223895A5050884242 @default.
• W4376223895 hasAuthorship W4376223895A5059179110 @default.
• W4376223895 hasAuthorship W4376223895A5062903733 @default.
• W4376223895 hasAuthorship W4376223895A5063594311 @default.
• W4376223895 hasAuthorship W4376223895A5067832646 @default.
• W4376223895 hasAuthorship W4376223895A5069893086 @default.
• W4376223895 hasAuthorship W4376223895A5072676408 @default.
• W4376223895 hasAuthorship W4376223895A5076016269 @default.
• W4376223895 hasAuthorship W4376223895A5083944564 @default.
• W4376223895 hasAuthorship W4376223895A5091927737 @default.
• W4376223895 hasBestOaLocation W43762238951 @default.
• W4376223895 hasConcept C137620995 @default.
• W4376223895 hasConcept C203014093 @default.
• W4376223895 hasConcept C502942594 @default.
• W4376223895 hasConcept C62478195 @default.
• W4376223895 hasConcept C86803240 @default.

• next